title: [Radio-induced oral and pharyngeal mucositis: management updates].
abstract: Mucositis is a major side effect induced by radiotherapy and/or chemotherapy of head and neck cancer. This toxicity impacts patient's quality of life and may compromise optimal treatments. Pathophysiology, risk factors, incidence and consequences of mucositis will be discussed in this review. Its management remains principally supportive (pain medication and nutritional support); however, in recent years several studies have revealed that the use of low level energy laser is particularly useful in the prevention and treatment of chemo- and radio-induced mucositis.
authors: Service de radiothérapie, CHU de Poitiers, France. e.caillot@gmail.com
authors: E
authors: E
authors: Caillot
authors: F
authors: F
authors: Denis
mesh_terms: D000700:Analgesics / Q000627:therapeutic use; D002921:Cicatrix / Q000209:etiology; D017281:Cost of Illness; D017679:Cryotherapy; D004750:Enteral Nutrition; D051523:Fibroblast Growth Factor 7 / Q000627:therapeutic use; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D028022:Low-Level Light Therapy; D052016:Mucositis / Q000209:etiology / Q000628:therapy*; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D010608:Pharyngeal Diseases / Q000209:etiology / Q000628:therapy*; D015995:Prevalence; D011878:Radiotherapy / Q000009:adverse effects*; D011879:Radiotherapy Dosage; D012307:Risk Factors; D013280:Stomatitis / Q000209:etiology / Q000628:therapy*; D014456:Ulcer / Q000209:etiology
chemical_list: D000700:Analgesics; D051523:Fibroblast Growth Factor 7